In contrast, cells without p21 displayed a pronounced mitotic arrest, irreversible DNA damage, the activation of apoptosis favorable MAPK/Erk pathway [54] and intense apoptosis induction (Fig. 8E), strongly indicative of a high efficacy of Plk1 inhibitors in p21-deficient tumor cells. The gene discussed is CDKN1A; the disease is neoplasm.